Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

Condition:   Amyotrophic Lateral Sclerosis Interventions:   Drug: Levosimendan;   Drug: Placebo for levosimendan Sponsor:   Orion Corporation, Orion Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials